Tardive Dyskinesia Across the Complexity Spectrum – From Quality of Life Improvement to Novel Treatments
Joohi Jimenez-Shahed, MD
Movement Disorders Neuromodulation and Brain Circuit Therapeutics
Icahn School of Medicine at Mount Sinai
New York, New York
Rajeev Kumar, MD, FRCPC
Director, Rocky Mountain Movement Disorders Center
Huntington's Disease Society of America Center of Excellence
Colorado Neurological Institute
This activity is designed for neurologists, nurse practitioners, nurses, physician assistants, and other healthcare professionals involved in the management of patients with neurological conditions.
After completing this activity, participants should be able to:
- Describe updated recommendations and screening strategies for improved TD recognition across the spectrum of TD severity and symptomatology
- Integrate key clinical trial data and updated guideline recommendations for treatment with VMAT2 inhibitors into clinical practice
- Develop cross-disciplinary care plans with psychiatry clinicians to facilitate improved collaborative care of patients with TD
This on-demand webcast is available with synchronized slides and audio.
To be eligible for documentation of credit, participants must complete the educational activity and complete the evaluation form. After successful completion of the evaluation form accessible at the right-hand side of this page, participants may immediately print their documentation of credit.
Participants who have successfully completed the live version of this activity, presented at Neurology Week (July 14-18, 2021) are not eligible to receive credit for this enduring webcast.
Release date: August 20, 2021
Expiration date: August 20, 2022
Estimated time to complete: 45 minutes
There is no fee associated with this activity.
For questions regarding this educational activity, please call 609-371-1137.
The evaluation is accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to firstname.lastname@example.org.
In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NACCME designates this internet enduring activity for a maximum of .75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This enduring activity is designated for .75 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.
This continuing nursing education enduring activity awards .75 contact hours.
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™from organizations accredited by the ACCME.
This enduring activity was planned by and for the healthcare team, and learners will receive .75 Interprofessional Continuing Education (IPCE) credit for learning and change.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by NACCME, LLC may contact Samantha Conforti, Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at email@example.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Conforti will review the grievance and respond within 30 days of receiving the complaint. If the participant is unsatisfied with the response, an appeal to the Associate Director, Greaton Sellers, Accreditation and Compliance, can be requested for a second level of review. Mr. Sellers can be contacted via phone at 609-371-1137, by email at firstname.lastname@example.org or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520.
Financial Disclosure and Conflicts of Interest
NACCME, LLC is an independent provider of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, NACCME is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- Any investigational, off-label, or non-FDA approved content or discussion
NACCME has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
The faculty has reported the following:
Joohi Jimenez-Shahed, MD; Advisory Board—AbbVie; Amneal; Boston Scientific; Impel; Revance; Roche/Genetech/Spark; St. Jude Medical; Consultant—Bracket; CNS Ratings; Nuvelution; Teva
Rajeev Kumar, MD: Advisory Board—Teva; Consultant—Teva; Speaker's Bureau—Teva
Calli Cook, DNP, FNP-C, FAANP: Advisory Board—AbbVie
NACCME planners and staff include Shoshana Cenker, Kristin Ciszeski, Samantha Conforti, Kathleen Hines, Mary Johnson, Randy Robbin, Greaton Sellers, Michelle Stewart, and Joanna Tong.
No NACCME planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).
Nurse Planner: Calli Cook, DNP, FNP-C, FAANP, Assistant Professor, Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2021 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
The following company has provided an educational grant in support of this activity: Neurocrine Biosciences